---
document_datetime: 2025-11-23 08:02:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-teva-generics-bv.html
document_name: clopidogrel-teva-generics-bv.html
version: success
processing_time: 0.1035565
conversion_datetime: 2025-12-24 03:06:56.760235
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel Teva Generics B.V.

[RSS](/en/individual-human-medicine.xml/65899)

##### Lapsed

This medicine's authorisation has lapsed

clopidogrel

Medicine

Human

Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 28 October 2010 the European Commission granted a marketing authorisation valid throughout the European Union (EU) for the medicinal product Clopidogrel Teva Generics B.V. (clopidogrel hydrochloride), indicated for the prevention of atherothrombotic events in patients with myocardial infarction and acute coronary syndrome.

It was also authorised for the prevention of atherothrombotic and thromboembolic events in atrial fibrillation. Clopidogrel Teva Generics B.V. has not been marketed in Europe since this initial marketing authorisation. In accordance with article 14(4) of Regulation (EC) No 726/2004 ('sunset clause')1 , the marketing authorisation of a medicinal product lapses if the product has never been marketed in one of the Member States within three years of its initial authorisation. Because of this, the marketing authorisation for Clopidogrel Teva Generics B.V. is no longer valid.

Clopidogrel Teva Generics B.V. is a generic medicine of Plavix. There are other generic medicinal products of Plavix authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Clopidogrel Teva Generics B.V. is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Clopidogrel Teva Generics B.V. : EPAR - Summary for the public

English (EN) (534.32 KB - PDF)

**First published:** 16/11/2010

**Last updated:** 12/05/2014

[View](/en/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-890)

български (BG) (699.01 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/bg/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_bg.pdf)

español (ES) (536.36 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/es/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_es.pdf)

čeština (CS) (602 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/cs/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_cs.pdf)

dansk (DA) (536.83 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/da/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_da.pdf)

Deutsch (DE) (598.25 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/de/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_de.pdf)

eesti keel (ET) (535.38 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/et/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_et.pdf)

ελληνικά (EL) (704.84 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/el/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_el.pdf)

français (FR) (596.76 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/fr/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_fr.pdf)

italiano (IT) (537.21 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/it/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_it.pdf)

latviešu valoda (LV) (606.28 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/lv/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (564.58 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/lt/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_lt.pdf)

magyar (HU) (597.43 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/hu/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_hu.pdf)

Malti (MT) (662.5 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/mt/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_mt.pdf)

Nederlands (NL) (536.78 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/nl/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_nl.pdf)

polski (PL) (603.79 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/pl/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_pl.pdf)

português (PT) (596.93 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/pt/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_pt.pdf)

română (RO) (563.69 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/ro/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_ro.pdf)

slovenčina (SK) (660.05 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sk/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_sk.pdf)

slovenščina (SL) (656.28 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sl/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_sl.pdf)

Suomi (FI) (536.19 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/fi/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_fi.pdf)

svenska (SV) (535.87 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sv/documents/overview/clopidogrel-teva-generics-bv-epar-summary-public_sv.pdf)

## Product information

Clopidogrel Teva Generics B.V. : EPAR - Product Information

English (EN) (760.93 KB - PDF)

**First published:** 16/11/2010

**Last updated:** 12/05/2014

[View](/en/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-501)

български (BG) (1.56 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/bg/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_bg.pdf)

español (ES) (800.58 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/es/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_es.pdf)

čeština (CS) (1.27 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/cs/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_cs.pdf)

dansk (DA) (772.04 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/da/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_da.pdf)

Deutsch (DE) (760.89 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/de/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_de.pdf)

eesti keel (ET) (832.55 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/et/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_et.pdf)

ελληνικά (EL) (1.56 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/el/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_el.pdf)

français (FR) (820.93 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/fr/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_fr.pdf)

hrvatski (HR) (364.4 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/hr/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_hr.pdf)

íslenska (IS) (209.31 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/is/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_is.pdf)

italiano (IT) (789.23 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/it/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_it.pdf)

latviešu valoda (LV) (1.24 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/lv/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_lv.pdf)

lietuvių kalba (LT) (868.2 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/lt/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_lt.pdf)

magyar (HU) (1.12 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/hu/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_hu.pdf)

Malti (MT) (1.19 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/mt/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_mt.pdf)

Nederlands (NL) (774.2 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/nl/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_nl.pdf)

norsk (NO) (233.6 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/no/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_no.pdf)

polski (PL) (1.26 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/pl/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_pl.pdf)

português (PT) (775.32 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/pt/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_pt.pdf)

română (RO) (906.23 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/ro/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_ro.pdf)

slovenčina (SK) (1.3 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sk/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_sk.pdf)

slovenščina (SL) (1.15 MB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sl/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_sl.pdf)

Suomi (FI) (757.07 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/fi/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_fi.pdf)

svenska (SV) (756.38 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sv/documents/product-information/clopidogrel-teva-generics-bv-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0010/G 05/11/2013

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Clopidogrel Teva Generics B.V. : EPAR - All Authorised presentations

English (EN) (494.76 KB - PDF)

**First published:** 16/11/2010

**Last updated:** 12/05/2014

[View](/en/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_en.pdf)

[Other languages (23)](#file-language-dropdown-760)

български (BG) (546.52 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/bg/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_bg.pdf)

español (ES) (489.81 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/es/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_es.pdf)

čeština (CS) (530.38 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/cs/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (489.46 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/da/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (488.85 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/de/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (489.46 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/et/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (542.27 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/el/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_el.pdf)

français (FR) (489.53 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/fr/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_fr.pdf)

íslenska (IS) (34.18 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/is/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_is.pdf)

italiano (IT) (488.67 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/it/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (533.43 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/lv/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (521.03 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/lt/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (532.93 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/hu/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (531.53 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/mt/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (488.38 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/nl/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (33.95 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/no/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_no.pdf)

polski (PL) (514.72 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/pl/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_pl.pdf)

português (PT) (489.62 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/pt/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_pt.pdf)

română (RO) (519.05 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/ro/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (514.96 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sk/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (500.95 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sl/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (490.74 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/fi/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (489.5 KB - PDF)

**First published:**

16/11/2010

**Last updated:**

12/05/2014

[View](/sv/documents/all-authorised-presentations/clopidogrel-teva-generics-bv-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Clopidogrel Teva Generics B.V. Active substance clopidogrel (as hydrochloride) International non-proprietary name (INN) or common name clopidogrel Therapeutic area (MeSH)

- Peripheral Vascular Diseases
- Acute Coronary Syndrome
- Myocardial Infarction
- Stroke

Anatomical therapeutic chemical (ATC) code B01AC04

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

- Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
- Patients suffering from acute coronary syndrome:
    - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).
    - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

For further information please refer to section 5.1.

## Authorisation details

EMA product number EMEA/H/C/002254

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Teva Pharma B.V.

Computerweg 10

Marketing authorisation issued 28/10/2010 Revision 3

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel Teva Generics B.V. : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (560.27 KB - PDF)

**First published:** 20/12/2011

**Last updated:** 12/05/2014

[View](/en/documents/procedural-steps-after/clopidogrel-teva-generics-bv-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Clopidogrel Teva Generics B.V. : EPAR - Public assessment report

English (EN) (922.86 KB - PDF)

**First published:** 16/11/2010

**Last updated:** 12/05/2014

[View](/en/documents/assessment-report/clopidogrel-teva-generics-bv-epar-public-assessment-report_en.pdf)

CHMP positive summary of opinion for Clopidogrel Teva Generics B.V.

Adopted

Reference Number: EMA/CHMP/455692/2010

English (EN) (518.47 KB - PDF)

**First published:** 23/07/2010

**Last updated:** 12/05/2014

[View](/en/documents/smop-initial/chmp-positive-summary-opinion-clopidogrel-teva-generics-bv_en.pdf)

**This page was last updated on** 12/05/2014

## Share this page

[Back to top](#main-content)